Biopharmaceuticals
Venture Capital
News Release - December 3, 2014
Naurex Raises $80 Million in Series C Financing to Advance Novel NMDA Receptor Modulators in Depression and Other CNS Disorders
Source: Naurex
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.